Sadhana Nitro Chem Valuation
Is SADHNANIQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Sales gegen Gleichaltrige
Price-To-Sales gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of SADHNANIQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: SADHNANIQ (₹63.5) wird über unserer Schätzung des Fair Value (₹0.83) gehandelt.
Deutlich unter dem Marktwert: SADHNANIQ über unserer Schätzung des beizulegenden Zeitwerts gehandelt wird.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SADHNANIQ?
Other financial metrics that can be useful for relative valuation.
What is SADHNANIQ's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₹17.74b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 11.2x |
Enterprise Value/EBITDA | 56.1x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does SADHNANIQ's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 3.6x | ||
532742 Paushak | 7.7x | n/a | ₹16.1b |
FAIRCHEMOR Fairchem Organics | 2.8x | n/a | ₹17.0b |
532834 Camlin Fine Sciences | 1x | 18.6% | ₹16.6b |
509874 Shalimar Paints | 2.8x | n/a | ₹14.8b |
SADHNANIQ Sadhana Nitro Chem | 10.2x | n/a | ₹17.7b |
Price-To-Sales gegen Gleichaltrige: SADHNANIQ ist auf der Grundlage des Price-To-Sales Verhältnisses (8.9x) im Vergleich zum Durchschnitt der Vergleichsgruppe (3.5x) teuer.
Price to Earnings Ratio vs Industry
How does SADHNANIQ's PE Ratio compare vs other companies in the IN Chemicals Industry?
Price-To-Sales gegen Industrie: SADHNANIQ ist teuer, wenn man sein Price-To-Sales Verhältnis (8.9x) mit dem Indian Chemicals Branchendurchschnitt (1.4x) vergleicht.
Price to Sales Ratio vs Fair Ratio
What is SADHNANIQ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 10.2x |
Fair PS Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Sales Fair Ratio von SADHNANIQ für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.